Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Bode, W' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 136 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Reverter, D; Strobl, S; Fernandez-Catalan, C; Sorimachi, H; Suzuki, K; Bode, W
      Structural basis for possible calcium-induced activation mechanisms of calpains

      BIOLOGICAL CHEMISTRY
    2. Schaschke, N; Matschiner, G; Zettl, F; Marquardt, U; Bergner, A; Bode, W; Sommerhoff, CP; Moroder, L
      Bivalent inhibition of human beta-tryptase

      CHEMISTRY & BIOLOGY
    3. Reverter, D; Sorimachi, H; Bode, W
      The structure of calcium-free human m-calpain - Implications for calcium activation and function

      TRENDS IN CARDIOVASCULAR MEDICINE
    4. Rester, U; Bode, W; Sampaio, CAM; Auerswald, EA; Lopes, APY
      Cloning, purification, crystallization and preliminary X-ray diffraction analysis of the antistasin-type inhibitor ghilanten (domain I) from Haementeria ghilianii in complex with porcine beta-trypsin

      ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
    5. Izumi, T; Kim, SW; Greist, A; Macedo-Ribeiro, S; Fuentes-Prior, P; Bode, W; Kane, WH; Ortel, TL
      Fine mapping of inhibitory anti-factor V antibodies using factor V C2 domain mutants - Identification of two antigenic epitopes involved in phospholipid binding

      THROMBOSIS AND HAEMOSTASIS
    6. Kairies, N; Beisel, HG; Fuentes-Prior, P; Tsuda, R; Muta, T; Iwanaga, S; Bode, W; Huber, R; Kawabata, S
      The 2.0-angstrom crystal structure of tachylectin 5A provides evidence forthe common origin of the innate immunity and the blood coagulation systems

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    7. Estebanez-Perpina, E; Bayes, A; Vendrell, J; Jongsma, MA; Bown, DP; Gatehouse, JA; Huber, R; Bode, W; Aviles, FX; Reverter, D
      Crystal structure of a novel mid-gut procarboxypeptidase from the cotton pest Helicoverpa armigera

      JOURNAL OF MOLECULAR BIOLOGY
    8. Lang, R; Kocourek, A; Braun, M; Tschesche, H; Huber, R; Bode, W; Maskos, K
      Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 angstrom crystal structure

      JOURNAL OF MOLECULAR BIOLOGY
    9. Brandstetter, H; Grams, F; Glitz, D; Lang, A; Haber, R; Bode, W; Krell, HW; Engh, RA
      The 1.8-angstrom crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition (vol 276, 17405, 2001)

      JOURNAL OF BIOLOGICAL CHEMISTRY
    10. Brandstetter, H; Grams, F; Glitz, D; Lang, A; Huber, R; Bode, W; Krell, HW; Engh, RA
      The 1.8-angstrom crystal structure of a matrix metallaproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition

      JOURNAL OF BIOLOGICAL CHEMISTRY
    11. Sperl, S; Bergner, A; Sturzebecher, J; Magdolen, V; Bode, W; Moroder, L
      Urethanyl-3-amidinophenylalanine derivatives as inhibitors of factor Xa. X-ray crystal structure of a trypsin/inhibitor complex and modeling studies

      BIOLOGICAL CHEMISTRY
    12. Estebanez-Perpina, E; Fuentes-Prior, P; Belorgey, D; Braun, M; Kiefersauer, R; Maskos, K; Huber, R; Rubin, H; Bode, W
      Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue

      BIOLOGICAL CHEMISTRY
    13. Ottl, J; Gabriel, D; Murphy, G; Knauper, V; Tominaga, Y; Nagase, H; Kroger, M; Tschesche, H; Bode, W; Moroder, L
      Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases

      CHEMISTRY & BIOLOGY
    14. Reverter, D; Fernandez-Catalan, C; Baumgartner, R; Pfander, R; Huber, R; Bode, W; Vendrell, J; Holak, TA; Aviles, FX
      Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2

      NATURE STRUCTURAL BIOLOGY
    15. Parry, MAA; Zhang, XC; Bode, W
      Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues

      TRENDS IN BIOCHEMICAL SCIENCES
    16. Rester, U; Moser, M; Huber, R; Bode, W
      L-Isoaspartate 115 of porcine beta-trypsin promotes crystallization of itscomplex with bdellastasin

      ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
    17. Masumoto, J; Nakagawa, K; Irie, S; Sorimachi, H; Suzuki, K; Bourenkov, GP; Bartunik, H; Fernandez-Catalan, C; Bode, W; Strobl, S
      Crystallization and preliminary X-ray analysis of recombinant full-length human m-calpain

      ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
    18. Richardson, JL; Kroger, B; Hoeffken, W; Sadler, JE; Pereira, P; Huber, R; Bode, W; Fuentes-Prior, P
      Crystal structure of the human alpha-thrombin-haemadin complex: an exositeII-binding inhibitor

      EMBO JOURNAL
    19. Sommerhoff, CP; Bode, W; Matschiner, G; Bergner, A; Fritz, H
      The human mast cell tryptase tetramer: a fascinating riddle solved by structure

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    20. Bode, W; Huber, R
      Structural basis of the endoproteinase-protein inhibitor interaction

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    21. Fuentes-Prior, P; Iwanaga, Y; Huber, R; Pagila, R; Rumennik, G; Seto, M; Morser, J; Light, DR; Bode, W
      Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex

      NATURE
    22. Strobl, S; Fernandez-Catalan, C; Braun, M; Huber, R; Masumoto, H; Nakagawa, K; Irie, A; Sorimachi, H; Bourenkow, G; Bartunik, H; Suzuki, K; Bode, W
      The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    23. Sperl, S; Jacob, U; de Prada, NA; Sturzebecher, J; Wilhelm, OG; Bode, W; Magdolen, V; Huber, R; Moroder, L
      (4-Aminomethyl)phenylguanidine derivatives as nonpeptidic highly selectiveinhibitors of human urokinase

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    24. Kim, SW; Quinn-Allen, MA; Camp, JT; Macedo-Ribeiro, S; Fuentes-Prior, P; Bode, W; Kane, WH
      Identification of functionally important amino acid residues within the C2-domain of human factor V using alanine-scanning mutagenesis

      BIOCHEMISTRY
    25. Bode, W; Maskos, K
      Structural studies on MMPs and TIMPs

      MATRIX METALLOPROTEINASE PROTOCOLS
    26. Bode, W; Fernandez-Catalan, C; Tschesche, H; Grams, F; Nagase, H; Maskos, K
      Structural properties of matrix metalloproteinases

      CELLULAR AND MOLECULAR LIFE SCIENCES
    27. Pereira, PJB; Lozanov, V; Patthy, A; Huber, R; Bode, W; Pongor, S; Strobl, S
      Specific inhibition of insect alpha-amylases: yellow meal worm alpha-amylase in complex with the Amaranth alpha-amylase inhibitor at 2.0 angstrom resolution

      STRUCTURE WITH FOLDING & DESIGN
    28. Hopfner, KP; Lang, A; Karcher, A; Sichler, K; Kopetzki, E; Brandstetter, H; Huber, R; Bode, W; Engh, RA
      Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substratebinding

      STRUCTURE WITH FOLDING & DESIGN
    29. Bode, W; Fernandez-Catalan, C; Nagase, H; Maskos, K
      Endoproteinase-protein inhibitor interactions

      APMIS
    30. Esmon, CT; Fukudome, K; Mather, T; Bode, W; Regan, LM; Stearns-Kurosawa, DJ; Kurosawa, S
      Inflammation, sepsis, and coagulation

      HAEMATOLOGICA
    31. Beisel, HG; Kawabata, S; Iwanaga, S; Huber, R; Bode, W
      Tachylectin-2: crystal structure of a specific GlcNAc/GalNAc-binding lectin involved in the innate immunity host defense of the Japanese horseshoe crab Tachypleus tridentatus

      EMBO JOURNAL
    32. Eichinger, A; Beisel, HG; Jacob, U; Huber, R; Medrano, FJ; Banbula, A; Potempa, J; Travis, J; Bode, W
      Crystal structure of gingipain R: an Arg-specific bacterial cysteine proteinase with a caspase-like fold

      EMBO JOURNAL
    33. Macedo-Ribeiro, S; Bode, W; Huber, R; Quinn-Allen, MA; Kim, SW; Ortel, TL; Bourenkov, GP; Bartunik, HD; Stubbs, MT; Kane, WH; Fuentes-Prior, P
      Crystal structures of the membrane-binding C2 domain of human coagulation factor V

      NATURE
    34. Sommerhoff, CP; Bode, W; Pereira, PJB; Stubbs, MT; Sturzebecher, J; Piechottka, GP; Matschiner, G; Bergner, A
      The structure of the human beta II-tryptase tetramer: Fo(u)r better or worse

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    35. Dekker, RJ; Eichinger, A; Stoop, AA; Bode, W; Pannekoek, H; Horrevoets, AJG
      Tine variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: Release of a kinetic block by a heterologous protein surface loop

      JOURNAL OF MOLECULAR BIOLOGY
    36. Pereira, PJB; Wang, ZM; Rubin, H; Huber, R; Bode, W; Schechter, NM; Strobl, S
      The 2.2 a crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: Structural explanation for its dipeptidyl carboxypeptidase specificity (vol 286, pg 163, 1998)

      JOURNAL OF MOLECULAR BIOLOGY
    37. Huber, R; Bode, W; Schechter, NM; Strobl, S
      The 2.2 angstrom crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: Structural explanation for its dipeptidyl carboxypeptidase specificity

      JOURNAL OF MOLECULAR BIOLOGY
    38. Meng, Q; Malinovskii, V; Huang, W; Hu, YJ; Chung, L; Nagase, H; Bode, W; Maskos, K; Brew, K
      Residue 2 of TIMP-1 is a major determinant of affinity and specificity formatrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1 ' residue of substrate

      JOURNAL OF BIOLOGICAL CHEMISTRY
    39. Steinmetzer, T; Renatus, M; Kunzel, S; Eichinger, A; Bode, W; Wikstrom, P; Hauptmann, J; Sturzebecher, J
      Design and evaluation of novel bivalent thrombin inhibitors based on amidinophenylalanines

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    40. STUBBS MT; RENATUS M; BODE W
      AN ACTIVE ZYMOGEN - UNRAVELING THE MYSTERY OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR

      Biological chemistry
    41. PARRY MAA; FERNANDEZCATALAN C; BERGNER A; HUBER R; HOPFNER KP; SCHLOTT B; GUHRS KH; BODE W
      THE TERNARY MICROPLASMIN-STAPHYLOKINASE-MICROPLASMIN COMPLEX IS A PROTEINASE-COFACTOR-SUBSTRATE COMPLEX IN ACTION

      Nature structural biology
    42. BANBULA A; POTEMPA J; TRAVIS J; FERNANDEZCATALAN C; MANN K; HUBER R; BODE W; MEDRANO FJ
      AMINO-ACID-SEQUENCE AND 3-DIMENSIONAL STRUCTURE OF THE STAPHYLOCOCCUS-AUREUS METALLOPROTEINASE AT 1.72 ANGSTROM RESOLUTION

      Structure
    43. PARRY MAA; JACOB U; HUBER R; WISNER A; BON C; BODE W
      THE CRYSTAL-STRUCTURE OF THE NOVEL SNAKE-VENOM PLASMINOGEN-ACTIVATOR TSV-PA - A PROTOTYPE STRUCTURE FOR SNAKE-VENOM SERINE PROTEINASES

      Structure
    44. BRANDSTETTER H; ENGH RA; VONROEDERN EG; MORODER L; HUBER R; BODE W; GRAMS F
      STRUCTURE OF MALONIC ACID-BASED INHIBITORS BOUND TO HUMAN NEUTROPHIL COLLAGENASE - A NEW BINDING MODE EXPLAINS APPARENTLY ANOMALOUS DATA

      Protein science
    45. BANBULA A; POTEMPA J; TRAVIS J; BODE W; MEDRANO FJ
      CRYSTALLIZATION AND PRELIMINARY-X-RAY DIFFRACTION ANALYSIS OF GINGIPAIN R2 FROM PORPHYROMONAS-GINGIVALIS IN COMPLEX WITH H-D-PHE-PHE-ARG-CHLOROMETHYLKETONE

      Protein science
    46. DETZNER HD; SCHRAMM W; DORING U; BODE W
      NEW TECHNOLOGY OF MECHANICAL TREATMENT OF DREDGED MATERIAL FROM HAMBURG HARBOR

      Water science and technology
    47. FERNANDEZCATALAN C; BODE W; HUBER R; TURK D; CALVETE JJ; LICHTE A; TSCHESCHE H; MASKOS K
      CRYSTAL-STRUCTURE OF THE COMPLEX FORMED BY THE MEMBRANE TYPE-1-MATRIX-METALLOPROTEINASE WITH THE TISSUE INHIBITOR OF METALLOPROTEINASES-2, THE SOLUBLE PROGELATINASE-A RECEPTOR

      EMBO journal (Print)
    48. MEDRANO FJ; ALONSO J; GARCIA JL; ROMERO A; BODE W; GOMISRUTH FX
      STRUCTURE OF PROLINE IMINOPEPTIDASE FROM XANTHOMONAS-CAMPESTRIS PV. CITRI - A PROTOTYPE FOR THE PROLYL OLIGOPEPTIDASE FAMILY

      EMBO journal
    49. PEREIRA PJB; BERGNER A; MACEDORIBEIRO S; HUBER R; MATSCHINER G; FRITZ H; SOMMERHOFF CP; BODE W
      HUMAN BETA-TRYPTASE IS A RING-LIKE TETRAMER WITH ACTIVE-SITES FACING A CENTRAL PORE

      Nature
    50. MASKOS K; FERNANDEZCATALAN C; HUBER R; BOURENKOV GP; BARTUNIK H; ELLESTAD GA; REDDY P; WOLFSON MF; RAUCH CT; CASTNER BJ; DAVIS R; CLARKE HRG; PETERSEN M; FITZNER JN; CERRETTI DP; MARCH CJ; PAXTON RJ; BLACK RA; BODE W
      CRYSTAL-STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN TUMOR NECROSIS FACTOR-ALPHA-CONVERTING ENZYME

      Proceedings of the National Academy of Sciences of the United Statesof America
    51. HOPFNER KP; KOPETZKI E; KRESSE GB; BODE W; HUBER R; ENGH RA
      NEW ENZYME LINEAGES BY SUBDOMAIN SHUFFLING

      Proceedings of the National Academy of Sciences of the United Statesof America
    52. Tuuttila, A; Morgunova, E; Bergmann, U; Lindqvist, Y; Maskos, K; Fernandez-Catalan, C; Bode, W; Tryggvason, K; Schneider, G
      Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 angstrom resolution

      JOURNAL OF MOLECULAR BIOLOGY
    53. GABRIEL B; STUBBS MT; BERGNER A; HAUPTMANN J; BODE W; STURZEBECHER J; MORODER L
      DESIGN OF BENZAMIDINE-TYPE INHIBITORS OF FACTOR XA

      Journal of medicinal chemistry
    54. VONROEDERN EG; BRANDSTETTER H; ENGH RA; BODE W; GRAMS F; MORODER L
      BIS-SUBSTITUTED MALONIC-ACID HYDROXAMATE DERIVATIVES AS INHIBITORS OFHUMAN NEUTROPHIL COLLAGENASE (MMP8)

      Journal of medicinal chemistry
    55. Renatus, M; Bode, W; Huber, R; Sturzebecher, J; Stubbs, MT
      Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: Implications for the inhibition of factor Xa, tPA, and urokinase

      JOURNAL OF MEDICINAL CHEMISTRY
    56. CHANG JL; JIN JP; LOLLAR P; BODE W; BRANDSTETTER H; HAMAGUCHI N; STRAIGHT DL; STAFFORD DW
      CHANGING RESIDUE-338 IN HUMAN FACTOR-IX FROM ARGININE TO ALANINE CAUSES AN INCREASE IN CATALYTIC ACTIVITY

      The Journal of biological chemistry
    57. LANS TE; BODE W; DEGRAAF EJR
      TRANSANAL ENDOSCOPIC MICROSURGERY - AN EASY WAY FOR LOCAL FORMALIN APPLICATION IN HEMORRHAGIC PROCTITIS

      Gastroenterology
    58. GOMISRUTH FX; GOMEZORTIZ M; VENDRELL J; VENTURA S; BODE W; HUBER R; AVILES FX
      CUTTING AT THE RIGHT PLACE - THE IMPORTANCE OF SELECTIVE LIMITED PROTEOLYSIS IN THE ACTIVATION OF PROPROTEINASE-E

      European journal of biochemistry
    59. BODE W; FRITZ H
      HUBER,ROBERT - A LIFE DEVOTED TO PROTEIN STRUCTURES AND FUNCTIONS

      Biological chemistry
    60. BERGNER A; MUTA T; IWANAGA S; BEISEL HG; DELOTTO R; BODE W
      HORSESHOE-CRAB COAGULOGEN IS AN INVERTEBRATE PROTEIN WITH A NERVE GROWTH FACTOR-LIKE DOMAIN

      Biological chemistry
    61. ESMON CT; FUKUDOME K; MATHER T; BODE W; ESMON NL; REGAN LM; STEARNSKUROSAWA DJ; KUROSAWA S
      INFLAMMATION - THE PROTEIN-C PATHWAY

      Fibrinolysis & proteolysis
    62. BODE W; RENATUS M
      TISSUE-TYPE PLASMINOGEN-ACTIVATOR - VARIANTS AND CRYSTAL SOLUTION STRUCTURES DEMARCATE STRUCTURAL DETERMINANTS OF FUNCTION/

      Current opinion in structural biology
    63. BODE W; BRANDSTETTER H; MATHER T; STUBBS MT
      COMPARATIVE-ANALYSIS OF HEMOSTATIC PROTEINASES - STRUCTURAL ASPECTS OF THROMBIN, FACTOR XA, FACTOR IXA AND PROTEIN-C

      Thrombosis and haemostasis
    64. PIEPER M; BETZ M; BUDISA N; GOMISRUTH FX; BODE W; TSCHESCHE H
      EXPRESSION, PURIFICATION, CHARACTERIZATION, AND X-RAY-ANALYSIS OF SELENOMETHIONINE-215 VARIANT OF LEUKOCYTE COLLAGENASE

      Journal of protein chemistry
    65. SCHLOTER M; BODE W; HARTMANN A
      CHARACTERIZATION AND APPLICATION OF A STRAIN-SPECIFIC MONOCLONAL-ANTIBODY AGAINST THE RHIZOSPHERE BACTERIUM AZOSPIRILLUM-BRASILENSE WA5

      Hybridoma
    66. HOPFNER KP; BRANDSTETTER H; KARCHER A; KOPETZKI E; HUBER R; ENGH RA; BODE W
      CONVERTING BLOOD-COAGULATION FACTOR IXA INTO FACTOR XA - DRAMATIC INCREASE IN AMIDOLYTIC ACTIVITY IDENTIFIES IMPORTANT ACTIVE-SITE DETERMINANTS

      EMBO journal
    67. RENATUS M; ENGH RA; STUBBS MT; HUBER R; FISCHER S; KOHNERT U; BODE W
      LYSINE-156 PROMOTES THE ANOMALOUS PROENZYME ACTIVITY OF TPA - X-RAY CRYSTAL-STRUCTURE OF SINGLE-CHAIN HUMAN TPA

      EMBO journal
    68. VANDELOCHT A; BODE W; HUBER R; LEBONNIEC BF; STONE SR; ESMON CT; STUBBS MT
      THE THROMBIN E192Q-BPTI COMPLEX REVEALS GROSS STRUCTURAL REARRANGEMENTS - IMPLICATIONS FOR THE INTERACTION WITH ANTITHROMBIN AND THROMBOMODULIN

      EMBO journal
    69. GOMISRUTH FX; MASKOS K; BETZ M; BERGNER A; HUBER R; SUZUKI K; YOSHIDA N; NAGASE H; BREW K; BOURENKOV GP; BARTUNIK H; BODE W
      MECHANISM OF INHIBITION OF THE HUMAN MATRIX METALLOPROTEINASE STROMELYSIN-1 BY TIMP-1

      Nature
    70. FUENTESPRIOR P; NOESKEJUNGBLUT C; DONNER P; SCHLEUNING WD; HUBER R; BODE W
      STRUCTURE OF THE THROMBIN COMPLEX WITH TRIABIN, A LIPOCALIN-LIKE EXOSITE-BINDING INHIBITOR DERIVED FROM A TRIATOMINE BUG

      Proceedings of the National Academy of Sciences of the United Statesof America
    71. GOMISRUTH FX; GOMEZORTIZ M; VENDRELL J; VENTURA S; BODE W; HUBER R; AVILES FX
      CRYSTAL-STRUCTURE OF AN OLIGOMER OF PROTEOLYTIC ZYMOGENS - DETAILED CONFORMATIONAL-ANALYSIS OF THE BOVINE TERNARY COMPLEX AND IMPLICATIONS FOR THEIR ACTIVATION

      Journal of Molecular Biology
    72. BURGERING MJM; ORBONS LPM; VANDERDOELEN A; MULDERS J; THEUNISSEN HJM; GROOTENHUIS PDJ; BODE W; HUBER R; STUBBS MT
      THE 2ND KUNITZ DOMAIN OF HUMAN TISSUE FACTOR PATHWAY INHIBITOR - CLONING, STRUCTURE DETERMINATION AND INTERACTION WITH FACTOR XA

      Journal of Molecular Biology
    73. RENATUS M; BODE W; HUBER R; STURZEBECHER J; PRASA D; FISCHER S; KOHNERT U; STUBBS MT
      STRUCTURAL MAPPING OF THE ACTIVE-SITE SPECIFICITY DETERMINANTS OF HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR - IMPLICATIONS FOR THE DESIGN OF LOW-MOLECULAR-WEIGHT SUBSTRATES AND INHIBITORS

      The Journal of biological chemistry
    74. STUBBS MT; MORENWEISER R; STURZEBECHER J; BAUER M; BODE W; HUBER R; PIECHOTTKA GP; MATSCHINER G; SOMMERHOFF CP; FRITZ H; AUERSWALD EA
      THE 3-DIMENSIONAL STRUCTURE OF RECOMBINANT LEECH-DERIVED TRYPTASE INHIBITOR IN COMPLEX WITH TRYPSIN - IMPLICATIONS FOR THE STRUCTURE OF HUMAN MAST-CELL TRYPTASE AND ITS INHIBITION

      The Journal of biological chemistry
    75. KE SH; TACHIAS K; LAMBA D; BODE W; MADISON EL
      IDENTIFICATION OF A HYDROPHOBIC EXOSITE ON TISSUE-TYPE PLASMINOGEN-ACTIVATOR THAT MODULATES SPECIFICITY FOR PLASMINOGEN

      The Journal of biological chemistry
    76. STURZEBECHER J; KOPETZKI E; BODE W; HOPFNER KP
      DRAMATIC ENHANCEMENT OF THE CATALYTIC ACTIVITY OF COAGULATION-FACTOR IXA BY ALCOHOLS

      FEBS letters
    77. MEDRANO FJ; ALONSO J; GARCIA JL; BODE W; GOMISRUTH FX
      CRYSTALLIZATION AND PRELIMINARY-X-RAY DIFFRACTION ANALYSIS OF PROLINEIMINOPEPTIDASE FROM XANTHOMONAS-CAMPESTRIS PV CITRI

      FEBS letters
    78. BETZ M; HUXLEY P; DAVIES SJ; MUSHTAQ Y; PIEPER M; TSCHESCHE H; BODE W; GOMISRUTH FX
      1.8-ANGSTROM CRYSTAL-STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN NEUTROPHIL COLLAGENASE (MATRIX METALLOPROTEINASE-8) COMPLEXED WITH A PEPTIDOMIMETIC HYDROXAMATE PRIME-SIDE INHIBITOR WITH A DISTINCT SELECTIVITY PROFILE

      European journal of biochemistry
    79. RENATUS M; STUBBS MT; HUBER R; BRINGMANN P; DONNER P; SCHLEUNING WD; BODE W
      CATALYTIC DOMAIN-STRUCTURE OF VAMPIRE BAT PLASMINOGEN-ACTIVATOR - A MOLECULAR PARADIGM FOR PROTEOLYSIS WITHOUT ACTIVATION CLEAVAGE

      Biochemistry
    80. GRAMS F; DIVE V; YIOTAKIS A; YIALLOUROS I; VASSILIOU S; ZWILLING R; BODE W; STOCKER W
      STRUCTURE OF ASTACIN WITH A TRANSITION-STATE ANALOG INHIBITOR

      Nature structural biology
    81. ENGH RA; BRANDSTETTER H; SUCHER G; EICHINGER A; BAUMANN U; BODE W; HUBER R; POLL T; RUDOLPH R; VONDERSAAL W
      ENZYME FLEXIBILITY, SOLVENT AND WEAK-INTERACTIONS CHARACTERIZE THROMBIN-LIGAND INTERACTIONS - IMPLICATIONS FOR DRUG DESIGN

      Structure
    82. BODE W; GRAMS F; REINEMER P; GOMISRUTH FX; BAUMANN U; MCKAY DB; STOCKER W
      THE METZINCINS - A SUPERFAMILY OF STRUCTURALLY RELATED METALLOPROTEINASES

      Zoology
    83. PIERSMA AH; BODE W; VERHOEF A; OLLING M
      TERATOGENICITY OF A SINGLE ORAL DOSE OF RETINYL PALMITATE IN THE RAT,AND THE ROLE OF DIETARY VITAMIN-A STATUS

      Pharmacology & toxicology
    84. TOET AE; VANDEKUIL A; VLEEMING W; WEMER J; BODE W; MEULENBELT J; DEWILDT DJ
      TOXIC DOSES OF RAC-PROPRANOLOL, (-)-(S)-PROPRANOLOL AND (-(R)-PROPRANOLOL IN RATS AND RABBITS())

      Chirality
    85. BERGNER A; OGANESSYAN V; MUTA T; IWANAGA S; TYPKE D; HUBER R; BODE W
      CRYSTAL-STRUCTURE OF COAGULOGEN, THE CLOTTING PROTEIN FROM HORSESHOE-CRAB - A STRUCTURAL HOMOLOG OF NERVE GROWTH-FACTOR

      EMBO journal
    86. MATHER T; OGANESSYAN V; HOF P; HUBER R; FOUNDLING S; ESMON C; BODE W
      THE 2.8-ANGSTROM CRYSTAL-STRUCTURE OF GLA-DOMAINLESS ACTIVATED PROTEIN-C

      EMBO journal
    87. VANDELOCHT A; STUBBS MT; BODE W; FRIEDRICH T; BOLLSCHWEILER C; HOFFKEN W; HUBER R
      THE ORNITHODORIN-THROMBIN CRYSTAL-STRUCTURE, A KEY TO THE TAP ENIGMA

      EMBO journal
    88. HOF P; MAYR I; HUBER R; KORZUS E; POTEMPA J; TRAVIS J; POWERS JC; BODE W
      THE 1.8 ANGSTROM CRYSTAL-STRUCTURE OF HUMAN CATHEPSIN-G IN COMPLEX WITH SUC-VAL-PRO-PHE(P)-(OPH)(2) - A JANUS-FACED PROTEINASE WITH 2 OPPOSITE SPECIFICITIES

      EMBO journal
    89. GOMISRUTH FX; GOHLKE U; BETZ M; KNAUPER V; MURPHY G; LOPEZOTIN C; BODE W
      THE HELPING HAND OF COLLAGENASE-3 (MMP-13) - 2.7 ANGSTROM CRYSTAL-STRUCTURE OF ITS C-TERMINAL HEMOPEXIN-LIKE DOMAIN

      Journal of Molecular Biology
    90. LAMBA D; BAUER M; HUBER R; FISCHER S; RUDOLPH R; KOHNERT U; BODE W
      THE 2.3 ANGSTROM CRYSTAL-STRUCTURE OF THE CATALYTIC DOMAIN OF RECOMBINANT 2-CHAIN HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR

      Journal of Molecular Biology
    91. VANDELOCHT A; STUBBS MT; BAUER M; BODE W
      CRYSTALLOGRAPHIC EVIDENCE THAT THE F2 KRINGLE CATALYTIC DOMAIN LINKEROF PROTHROMBIN DOES NOT COVER THE FIBRINOGEN RECOGNITION EXOSITE

      The Journal of biological chemistry
    92. BRANDSTETTER H; KUHNE A; BODE W; HUBER R; VONDERSAAL W; WIRTHENSOHN K; ENGH RA
      X-RAY STRUCTURE OF ACTIVE SITE-INHIBITED CLOTTING FACTOR XA - IMPLICATIONS FOR DRUG DESIGN AND SUBSTRATE RECOGNITION

      The Journal of biological chemistry
    93. OTTL J; BATTISTUTA R; PIEPER M; TSCHESCHE H; BODE W; KUHN K; MORODER L
      DESIGN AND SYNTHESIS OF HETEROTRIMERIC COLLAGEN PEPTIDES WITH A BUILT-IN CYSTINE-KNOT - MODELS FOR COLLAGEN CATABOLISM BY MATRIX-METALLOPROTEASES

      FEBS letters
    94. GOHLKE U; GOMISRUTH FX; CRABBE T; MURPHY G; DOCHERTY AJP; BODE W
      THE C-TERMINAL (HEMOPEXIN-LIKE) DOMAIN-STRUCTURE OF HUMAN GELATINASE-A (MMP2) - STRUCTURAL IMPLICATIONS FOR ITS FUNCTION

      FEBS letters
    95. BERGNER A; BAUER M; BRANDSTETTER H; STURZEBECHER J; BODE W
      THE X-RAY CRYSTAL-STRUCTURE OF THROMBIN IN COMPLEX WITH LFONYL-L-3-AMIDINO-PHENYLALANYL-4-METHYLPIPERIDIDE - THE BENEFICIAL EFFECT OF FILLING OUT AN EMPTY CAVITY

      Journal of enzyme inhibition
    96. STUBBS MT; BODE W
      STRUCTURE AND SPECIFICITY IN COAGULATION AND ITS INHIBITION

      Trends in cardiovascular medicine
    97. BODE W
      A HELPING HAND FOR COLLAGENASES - THE HEMOPEXIN-LIKE DOMAIN

      Structure
    98. STUBBS MT; BODE W
      THE CLOT THICKENS - CLUES PROVIDED BY THROMBIN STRUCTURE (VOL 20 PG 23, 1995)

      Trends in biochemical sciences
    99. STUBBS MT; BODE W
      THE CLOT THICKENS - CLUES PROVIDED BY THROMBIN STRUCTURE

      Trends in biochemical sciences
    100. STOCKER W; GRAMS F; BAUMANN U; REINEMER P; GOMISRUTH FX; MCKAY DB; BODE W
      THE METZINCINS - TOPOLOGICAL AND SEQUENTIAL RELATIONS BETWEEN THE ASTACINS, ADAMALYSINS, SERRALYSINS, AND MATRIXINS (COLLAGENASES) DEFINE ASUPERFAMILY OF ZINC-PEPTIDASES

      Protein science


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 23:34:51